Statins and Inflammation: New Therapeutic Opportunities in Psychiatry

被引:103
作者
Kim, Sung-Wan [1 ]
Kang, Hee-Ju [1 ]
Jhon, Min [1 ]
Kim, Ju-Wan [1 ]
Lee, Ju-Yeon [1 ]
Walker, Adam J. [2 ]
Agustini, Bruno [2 ]
Kim, Jae-Min [1 ]
Berk, Michael [2 ,3 ,4 ,5 ]
机构
[1] Chonnam Natl Univ, Sch Med, Dept Psychiat, Gwangju, South Korea
[2] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic, Australia
[3] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia
[4] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia
[5] Orygen, Natl Ctr Excellence Youth Mental Hlth, Parkville, Vic, Australia
基金
新加坡国家研究基金会; 澳大利亚国家健康与医学研究理事会;
关键词
statin; depression; schizophrenia; dementia; inflammation; C-REACTIVE-PROTEIN; MAJOR DEPRESSIVE DISORDER; LIPID-LOWERING DRUGS; N-ACETYL CYSTEINE; DOUBLE-BLIND; ALZHEIMERS-DISEASE; CHOLESTEROL LEVELS; COGNITIVE FUNCTION; CORONARY ATHEROSCLEROSIS; ANTIINFLAMMATORY AGENTS;
D O I
10.3389/fpsyt.2019.00103
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and anti-oxidant effects. These are thought to be responsible for the potential effects of statins on various psychiatric disorders. In this study, we comprehensively review the literature to investigate the effects of statins on various psychiatric disorders including depression, schizophrenia, and dementia. In addition, we review adverse effects and drug interactions of statins to give clinically useful information guiding statin use in the psychiatric field. Statins seem useful in reducing depression, particularly in patients with physical disorders such as cardiovascular disease. In patients with schizophrenia, negative symptoms may be reduced by adjuvant statin therapy. Studies on cohorts at risk for dementia have generally shown protective effects of statins, while those on treatment for dementia show inconsistent results. In conclusion, statins used in combination with conventional psychotropic medications may be effective for various psychiatric disorders including depression, schizophrenia, and dementia. Further study is required to determine optimal doses and duration of statin use for the treatment of psychiatric disorders.
引用
收藏
页数:16
相关论文
共 181 条
[1]   Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial [J].
Abbasi, Seyed Hesameddin ;
Mohammadinejad, Payam ;
Shahmansouri, Nazila ;
Salehiomran, Abbas ;
Beglar, Akram Arjmandi ;
Zeinoddini, Atefeh ;
Forghani, Saeedeh ;
Akhondzadeh, Shahin .
JOURNAL OF AFFECTIVE DISORDERS, 2015, 183 :149-155
[2]   Safety and efficacy of statin therapy [J].
Adhyaru, Bhavin B. ;
Jacobson, Terry A. .
NATURE REVIEWS CARDIOLOGY, 2018, 15 (12) :757-769
[3]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[4]   Initiation of statin therapy after acute myocardial infarction is not associated with worsening depressive symptoms: Insights from the Prospective Registry Evaluating Outcomes After Myocardial Infarctions: Events and Recovery (PREMIER) and Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) registries [J].
Al Badarin, Firas J. ;
Spertus, John A. ;
Gosch, Kensey L. ;
Buchanan, Donna M. ;
Chan, Paul S. .
AMERICAN HEART JOURNAL, 2013, 166 (05) :879-886
[5]   Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin [J].
Ampuero, Javier ;
Romero-Gomez, Manuel .
WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (08) :1105-1111
[6]   Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications [J].
Anderson, George ;
Berk, Michael ;
Dean, Olivia ;
Moylan, Steven ;
Maes, Michael .
CNS DRUGS, 2014, 28 (01) :1-10
[7]   Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia [J].
Anderson, George ;
Berk, Michael ;
Dodd, Seetal ;
Bechter, Karl ;
Altamura, A. Carlo ;
Dell'Osso, Bernardo ;
Kanba, Shigenobu ;
Monji, Akira ;
Fatemi, S. Hossein ;
Buckley, Peter ;
Debnath, Monojit ;
Das, U. N. ;
Meyer, Urs ;
Mueller, Norbert ;
Kanchanatawan, Buranee ;
Maes, Michael .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 42 :1-4
[8]   RATES OF CHOLESTEROL, UBIQUINONE, DOLICHOL AND DOLICHYL-P BIOSYNTHESIS IN RAT-BRAIN SLICES [J].
ANDERSSON, M ;
ELMBERGER, PG ;
EDLUND, C ;
KRISTENSSON, K ;
DALLNER, G .
FEBS LETTERS, 1990, 269 (01) :15-18
[9]  
Andrade C, 2017, EVID-BASED MENT HEAL, V20, P60, DOI 10.1136/eb-2016-102566
[10]   Stress, immunity, cytokines and depression [J].
Anisman, H .
ACTA NEUROPSYCHIATRICA, 2002, 14 (06) :251-261